These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 10690326)
1. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Leiper J; Vallance P Cardiovasc Res; 1999 Aug; 43(3):542-8. PubMed ID: 10690326 [TBL] [Abstract][Full Text] [Related]
2. [Biological and pathophysiological roles of endogenous methylarginines as inhibitors of nitric oxide synthase]. Masuda H; Azuma H Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):29-35. PubMed ID: 11862754 [TBL] [Abstract][Full Text] [Related]
3. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Tojo A; Welch WJ; Bremer V; Kimoto M; Kimura K; Omata M; Ogawa T; Vallance P; Wilcox CS Kidney Int; 1997 Dec; 52(6):1593-601. PubMed ID: 9407505 [TBL] [Abstract][Full Text] [Related]
4. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes. Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528 [TBL] [Abstract][Full Text] [Related]
6. Roles of endogenous nitric oxide synthase inhibitors and endothelin-1 for regulating myometrial contractions during gestation in the rat. Momohara Y; Sakamoto S; Obayashi S; Aso T; Goto M; Azuma H Mol Hum Reprod; 2004 Jul; 10(7):505-12. PubMed ID: 15155819 [TBL] [Abstract][Full Text] [Related]
7. DdaR (PA1196) Regulates Expression of Dimethylarginine Dimethylaminohydrolase for the Metabolism of Methylarginines in Pseudomonas aeruginosa PAO1. Lundgren BR; Bailey FJ; Moley G; Nomura CT J Bacteriol; 2017 Apr; 199(8):. PubMed ID: 28167521 [TBL] [Abstract][Full Text] [Related]
8. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. MacAllister RJ; Parry H; Kimoto M; Ogawa T; Russell RJ; Hodson H; Whitley GS; Vallance P Br J Pharmacol; 1996 Dec; 119(8):1533-40. PubMed ID: 8982498 [TBL] [Abstract][Full Text] [Related]
9. Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin. Cardounel AJ; Xia Y; Zweier JL J Biol Chem; 2005 Mar; 280(9):7540-9. PubMed ID: 15574418 [TBL] [Abstract][Full Text] [Related]
10. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. MacAllister RJ; Fickling SA; Whitley GS; Vallance P Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309 [TBL] [Abstract][Full Text] [Related]
11. Pharmacology and clinical pharmacology of methylarginines used as inhibitors of nitric oxide synthases. Kittel A; Maas R Curr Pharm Des; 2014; 20(22):3530-47. PubMed ID: 24180385 [TBL] [Abstract][Full Text] [Related]
12. Roles of accumulated endogenous nitric oxide synthase inhibitors and decreased nitric oxide synthase activity for impaired trigonal relaxation with ischemia. Masuda H; Yano M; Sakai Y; Kihara K; Goto M; Azuma H J Urol; 2003 Oct; 170(4 Pt 1):1415-20. PubMed ID: 14501780 [TBL] [Abstract][Full Text] [Related]
13. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine. Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890 [TBL] [Abstract][Full Text] [Related]
14. Effect of asymmetric dimethylarginine (ADMA) on heart failure development. Liu X; Hou L; Xu D; Chen A; Yang L; Zhuang Y; Xu Y; Fassett JT; Chen Y Nitric Oxide; 2016 Apr; 54():73-81. PubMed ID: 26923818 [TBL] [Abstract][Full Text] [Related]
15. Localization and role of nitric oxide synthase and endogenous nitric oxide synthase inhibitors in the rabbit lower urinary tract. Masuda H; Tsujii T; Okuno T; Kihara K; Goto M; Azuma H J Urol; 2002 May; 167(5):2235-40. PubMed ID: 11956485 [TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Böger RH; Bode-Böger SM Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953 [TBL] [Abstract][Full Text] [Related]
18. The methylarginines NMMA, ADMA, and SDMA are ubiquitous constituents of the main vegetables of human nutrition. Servillo L; Giovane A; Cautela D; Castaldo D; Balestrieri ML Nitric Oxide; 2013 Apr; 30():43-8. PubMed ID: 23438481 [TBL] [Abstract][Full Text] [Related]
19. Endogenous production of nitric oxide synthase inhibitors. Anthony S; Leiper J; Vallance P Vasc Med; 2005 Jul; 10 Suppl 1():S3-9. PubMed ID: 16444863 [TBL] [Abstract][Full Text] [Related]
20. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency. Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]